271 related articles for article (PubMed ID: 25355217)
21. p53 and NF 1 loss plays distinct but complementary roles in glioma initiation and progression.
Gonzalez PP; Kim J; Galvao RP; Cruickshanks N; Abounader R; Zong H
Glia; 2018 May; 66(5):999-1015. PubMed ID: 29392777
[TBL] [Abstract][Full Text] [Related]
22. Transformation of quiescent adult oligodendrocyte precursor cells into malignant glioma through a multistep reactivation process.
Galvao RP; Kasina A; McNeill RS; Harbin JE; Foreman O; Verhaak RG; Nishiyama A; Miller CR; Zong H
Proc Natl Acad Sci U S A; 2014 Oct; 111(40):E4214-23. PubMed ID: 25246577
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical study of neural stem cell lineage markers in canine brains, gliomas, and a glioma cell line.
Yoshida K; Chambers JK; Uchida K
Vet Pathol; 2023 Jan; 60(1):35-46. PubMed ID: 36384382
[TBL] [Abstract][Full Text] [Related]
24. Expression of Oligodendrocyte Precursor Cell Markers in Canine Oligodendrogliomas.
Kishimoto TE; Uchida K; Thongtharb A; Shibato T; Chambers JK; Nibe K; Kagawa Y; Nakayama H
Vet Pathol; 2018 Sep; 55(5):634-644. PubMed ID: 29852819
[TBL] [Abstract][Full Text] [Related]
25. Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma.
Kraus JA; Koopmann J; Kaskel P; Maintz D; Brandner S; Schramm J; Louis DN; Wiestler OD; von Deimling A
J Neuropathol Exp Neurol; 1995 Jan; 54(1):91-5. PubMed ID: 7815084
[TBL] [Abstract][Full Text] [Related]
26. Capicua regulates neural stem cell proliferation and lineage specification through control of Ets factors.
Ahmad ST; Rogers AD; Chen MJ; Dixit R; Adnani L; Frankiw LS; Lawn SO; Blough MD; Alshehri M; Wu W; Marra MA; Robbins SM; Cairncross JG; Schuurmans C; Chan JA
Nat Commun; 2019 May; 10(1):2000. PubMed ID: 31043608
[TBL] [Abstract][Full Text] [Related]
27. Oligodendroglial tumors with marked desmoplasia: clinicopathologic and molecular features of 7 cases.
Jentoft M; Giannini C; Rossi S; Mota R; Jenkins RB; Rodriguez FJ
Am J Surg Pathol; 2011 Jun; 35(6):845-52. PubMed ID: 21552114
[TBL] [Abstract][Full Text] [Related]
28. Combination of a ptgs2 inhibitor and an epidermal growth factor receptor-signaling inhibitor prevents tumorigenesis of oligodendrocyte lineage-derived glioma-initiating cells.
Hide T; Takezaki T; Nakatani Y; Nakamura H; Kuratsu J; Kondo T
Stem Cells; 2011 Apr; 29(4):590-9. PubMed ID: 21360625
[TBL] [Abstract][Full Text] [Related]
29. Shared epigenetic mechanisms in human and mouse gliomas inactivate expression of the growth suppressor SLC5A8.
Hong C; Maunakea A; Jun P; Bollen AW; Hodgson JG; Goldenberg DD; Weiss WA; Costello JF
Cancer Res; 2005 May; 65(9):3617-23. PubMed ID: 15867356
[TBL] [Abstract][Full Text] [Related]
30. [Analysis of S100beta-v-erbB transgenic rats prone to brain tumors].
Yokoo H; Tanaka Y; Nobusawa S; Nakazato Y; Ohgaki H
Brain Nerve; 2009 Jul; 61(7):765-72. PubMed ID: 19618853
[TBL] [Abstract][Full Text] [Related]
31. Role of perfusion-weighted imaging at 3T in the histopathological differentiation between astrocytic and oligodendroglial tumors.
Saito T; Yamasaki F; Kajiwara Y; Abe N; Akiyama Y; Kakuda T; Takeshima Y; Sugiyama K; Okada Y; Kurisu K
Eur J Radiol; 2012 Aug; 81(8):1863-9. PubMed ID: 21543173
[TBL] [Abstract][Full Text] [Related]
32. Mouse Models of Pediatric Supratentorial High-grade Glioma Reveal How Cell-of-Origin Influences Tumor Development and Phenotype.
Sreedharan S; Maturi NP; Xie Y; Sundström A; Jarvius M; Libard S; Alafuzoff I; Weishaupt H; Fryknäs M; Larsson R; Swartling FJ; Uhrbom L
Cancer Res; 2017 Feb; 77(3):802-812. PubMed ID: 28115362
[TBL] [Abstract][Full Text] [Related]
33. Molecular pathways in the formation of gliomas.
von Deimling A; Louis DN; Wiestler OD
Glia; 1995 Nov; 15(3):328-38. PubMed ID: 8586467
[TBL] [Abstract][Full Text] [Related]
34. Oligodendroglial-specific transcriptional factor SOX10 is ubiquitously expressed in human gliomas.
Bannykh SI; Stolt CC; Kim J; Perry A; Wegner M
J Neurooncol; 2006 Jan; 76(2):115-27. PubMed ID: 16205963
[TBL] [Abstract][Full Text] [Related]
35. Coexpression of cyclin D1 and alpha-internexin in oligodendroglial tumors.
Matsumura N; Nobusawa S; Ikota H; Hirato J; Hirose T; Yokoo H; Nakazato Y
Brain Tumor Pathol; 2015 Oct; 32(4):261-7. PubMed ID: 26233522
[TBL] [Abstract][Full Text] [Related]
36. Astrocytes give rise to oligodendrogliomas and astrocytomas after gene transfer of polyoma virus middle T antigen in vivo.
Holland EC; Li Y; Celestino J; Dai C; Schaefer L; Sawaya RA; Fuller GN
Am J Pathol; 2000 Sep; 157(3):1031-7. PubMed ID: 10980141
[TBL] [Abstract][Full Text] [Related]
37. Native Oligodendrocytes in Astrocytomas Might Inhibit Tumor Proliferation by WIF1 Expression.
Asslaber M; Schauer S; Gogg-Kamerer M; Bernhart E; Quehenberger F; Haybaeck J
J Neuropathol Exp Neurol; 2017 Jan; 76(1):16-26. PubMed ID: 28040794
[TBL] [Abstract][Full Text] [Related]
38. Molecular genetic evidence for subtypes of oligoastrocytomas.
Maintz D; Fiedler K; Koopmann J; Rollbrocker B; Nechev S; Lenartz D; Stangl AP; Louis DN; Schramm J; Wiestler OD; von Deimling A
J Neuropathol Exp Neurol; 1997 Oct; 56(10):1098-104. PubMed ID: 9329453
[TBL] [Abstract][Full Text] [Related]
39. "Angioglioma" and the arteriovenous malformation-glioma association.
Lombardi D; Scheithauer BW; Piepgras D; Meyer FB; Forbes GS
J Neurosurg; 1991 Oct; 75(4):589-66. PubMed ID: 1885977
[TBL] [Abstract][Full Text] [Related]
40. Oligodendrogliomas with neurocytic differentiation. A report of 4 cases with diagnostic and histogenetic implications.
Perry A; Scheithauer BW; Macaulay RJ; Raffel C; Roth KA; Kros JM
J Neuropathol Exp Neurol; 2002 Nov; 61(11):947-55. PubMed ID: 12430711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]